A Study to Evaluate INCA036873 in Participants With Advanced Solid Tumors and Hematological Malignancies
Incyte Corporation
Incyte Corporation
National Cancer Institute (NCI)
Alliance for Clinical Trials in Oncology
Hoffmann-La Roche
Genmab
St. Jude Children's Research Hospital
Mayo Clinic
Cancer Research UK
St. Jude Children's Research Hospital
Shattuck Labs, Inc.
RenJi Hospital
National Cancer Institute (NCI)
Checkpoint Therapeutics, Inc.
Taproot Health
Celldex Therapeutics
Corvus Pharmaceuticals, Inc.
Rutgers, The State University of New Jersey
Fate Therapeutics
Hoffmann-La Roche
City of Hope Medical Center
Fate Therapeutics
Scripps Health
Incyte Corporation
Incyte Corporation
MultiVir, Inc.
Celgene
Pfizer
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Shenzhen BinDeBio Ltd.
University of Southern California
Fred Hutchinson Cancer Center
Daiichi Sankyo
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Stanford University
National Institutes of Health Clinical Center (CC)
Seagen Inc.
Celldex Therapeutics
Masonic Cancer Center, University of Minnesota
Wake Forest University Health Sciences
University of Arizona
Novartis
Mirna Therapeutics, Inc.
Pfizer
Stanford University
Rutgers, The State University of New Jersey
Seagen Inc.
National Cancer Institute (NCI)
INSYS Therapeutics Inc